P. R. Bock, J. Hanisch, H. Matthes, K. S. Zanker, P. N. Harter et al., Targeting inflammation in cancer-related-fatigue: A rationale for mistletoe therapy as supportive care in colorectal cancer patients. Inflamm. Allergy Drug Targets Fermented mistletoe extract as a multimodal antitumoral agent in gliomas, pp.105-111, 2012.

G. S. Kienle, F. Berrino, A. Bussing, E. Portalupi, S. Rosenzweig et al., Mistletoe in cancer?A systematic review on controlled clinical trials European Viscum album: A potent phytotherapeutic agent with multifarious phytochemicals, pharmacological properties and clinical evidence, Eur. J. Med. Res, vol.8, issue.6, pp.109-119, 2003.

M. Augustin, P. R. Bock, J. Hanisch, M. Karasmann, and B. Schneider, Safety and efficacy of the long-term adjuvant treatment of primary intermediate-to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland, Arzneimittelforschung, vol.55, pp.38-49, 2005.

J. Melzer, F. Iten, K. Hostanska, and R. Saller, Efficacy and Safety of Mistletoe Preparations (Viscum album) for Patients with Cancer Diseases, Forschende Komplement??rmedizin / Research in Complementary Medicine, vol.16, issue.4, pp.217-226, 2009.
DOI : 10.1159/000226249

Y. Endo, K. Tsurugi, and H. Franz, -glycosidase activity of the protein, FEBS Letters, vol.43, issue.2, pp.378-380, 1988.
DOI : 10.1016/0014-5793(88)80853-6

URL : https://hal.archives-ouvertes.fr/hal-00907229

F. Stirpe, L. Barbieri, M. G. Battelli, M. Soria, D. A. Lappi et al., Ribosome???Inactivating Proteins from Plants: Present Status and Future Prospects, Bio/Technology, vol.18, issue.4, pp.405-412, 1992.
DOI : 10.1038/nbt0492-405

H. Nakano, K. L. Lin, M. Yanagita, C. Charbonneau, D. N. Cook et al., Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses, Nature Immunology, vol.27, issue.4, pp.394-402, 2009.
DOI : 10.1038/ni.1707

B. Pulendran, H. Tang, and S. Manicassamy, Programming dendritic cells to induce TH2 and tolerogenic responses, Nature Immunology, vol.197, issue.8, pp.647-655, 2010.
DOI : 10.1038/ni.1894

H. Hammad, M. Plantinga, K. Deswarte, P. Pouliot, M. A. Willart et al., Inflammatory dendritic cells???not basophils???are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen, The Journal of Experimental Medicine, vol.21, issue.10, pp.2097-2111, 2010.
DOI : 10.1016/S0092-8674(00)80240-8

E. Segura, M. Touzot, A. Bohineust, A. Cappuccio, G. Chiocchia et al., Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation, Immunity, vol.38, issue.2, pp.336-348, 2013.
DOI : 10.1016/j.immuni.2012.10.018

M. S. Maddur, M. Sharma, P. Hegde, E. Stephen-victor, B. Pulendran et al., Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand, Nature Communications, vol.141, pp.2014-4092
DOI : 10.1073/pnas.90.8.3730

K. L. Lewis and B. Reizis, Dendritic Cells: Arbiters of Immunity and Immunological Tolerance, Cold Spring Harbor Perspectives in Biology, vol.4, issue.8
DOI : 10.1101/cshperspect.a007401

C. Vitali, F. Mingozzi, A. Broggi, S. Barresi, F. Zolezzi et al., Migratory, and not lymphoid-resident, dendritic cells maintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells, Blood, vol.120, issue.6, pp.1237-1245, 2012.
DOI : 10.1182/blood-2011-09-379776

Z. Li, D. Li, A. Tsunn, and B. Li, FOXP3+ regulatory T cells and their functional regulation, Cellular and Molecular Immunology, vol.3, issue.5, pp.558-565
DOI : 10.1073/pnas.1408780111

J. Bayry, Repressing Immunity in Autoimmune Disease, New England Journal of Medicine, vol.374, issue.21, pp.2090-2092
DOI : 10.1056/NEJMcibr1602864

B. Almand, J. R. Resser, B. Lindman, S. Nadaf, J. I. Clark et al., Gabrilovich, D.I. Clinical significance of defective dendritic cell differentiation n cancer, Clin. Cancer Res, vol.6, pp.1755-1766, 2000.

A. P. Vicari, C. Caux, and G. Trinchieri, Tumour escape from immune surveillance through dendritic cell inactivation, Seminars in Cancer Biology, vol.12, issue.1, pp.33-42, 2002.
DOI : 10.1006/scbi.2001.0400

D. I. Gabrilovich, J. Corak, I. F. Ciernik, D. Kavanaugh, and D. P. Carbone, Decreased antigen presentation by dendritic cells in patients with breast cancer, Clin. Cancer Res, vol.3, pp.483-490, 1997.

H. Saito, S. Tsujitani, M. Ikeguchi, M. Maeta, and N. Kaibara, Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue, British Journal of Cancer, vol.78, issue.12, pp.1573-1577, 1998.
DOI : 10.1038/bjc.1998.725

H. Dong and T. N. Bullock, Metabolic Influences That Regulate Dendritic Cell Function in Tumors, Frontiers in Immunology, vol.5, issue.5, p.24
DOI : 10.3389/fimmu.2014.00024

K. M. Hargadon and T. N. Bullock, The Role of Tumor/Dendritic Cell Interactions in the Regulation of Anti-Tumor Immunity: The Good, the Bad, and the Ugly, Frontiers in Immunology, vol.4, p.178, 2014.
DOI : 10.3389/fimmu.2013.00371

S. R. Elluru, J. P. Duong-van-huyen, S. Delignat, M. D. Kazatchkine, A. Friboulet et al., Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum albumas complimentary therapy in cancer, BMC Cancer, vol.210, issue.9, p.161, 2008.
DOI : 10.1016/j.imbio.2005.07.004

F. Knopfl-sidler, A. Viviani, L. Rist, and A. Hensel, Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts, Pharmazie, vol.60, pp.448-454, 2005.

H. Hulsen, C. Doser, and F. Mechelke, Differences in the in vitro effectiveness of preparations produced from mistletoes of various host trees, Arzneimittelforschung, vol.36, pp.433-436, 1986.

J. Kleijnen and P. Knipschild, Mistletoe treatment for cancer review of controlled trials in humans, Phytomedicine, vol.1, issue.3, pp.255-260, 1994.
DOI : 10.1016/S0944-7113(11)80073-5

G. Ribereau-gayon, M. L. Jung, D. Di-scala, and J. P. Beck, Comparison of the Effects of Fermented and Unfermented Mistletoe Preparations on Cultured Tumor Cells, Oncology, vol.43, issue.1, pp.35-41, 1986.
DOI : 10.1159/000226418

J. Eggenschwiler, L. Von-balthazar, B. Stritt, D. Pruntsch, M. Ramos et al., Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata), BMC Complementary and Alternative Medicine, vol.25, issue.6A, p.14, 2007.
DOI : 10.1042/bj20030488

N. Xu, X. Li, and Y. Zhong, Inflammatory Cytokines: Potential Biomarkers of Immunologic Dysfunction in Autism Spectrum Disorders, Mediators of Inflammation, vol.8, issue.3, 2015.
DOI : 10.1111/j.1471-4159.2009.06432.x

E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini, Functions of natural killer cells, Nature Immunology, vol.178, issue.5, pp.503-510, 2008.
DOI : 10.1073/pnas.050588297

URL : https://hal.archives-ouvertes.fr/hal-00294184

V. Shankaran, H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson et al., IFN? and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, vol.410, issue.6832, pp.1107-1111, 2001.
DOI : 10.1038/35074122

S. Hong, J. Qian, J. Yang, H. Li, L. W. Kwak et al., Roles of Idiotype-Specific T Cells in Myeloma Cell Growth and Survival: Th1 and CTL Cells Are Tumoricidal while Th2 Cells Promote Tumor Growth, Cancer Research, vol.68, issue.20, pp.8456-8464, 2008.
DOI : 10.1158/0008-5472.CAN-08-2213

D. H. Kaplan, V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet et al., Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice, Proc. Natl. Acad

K. Palucka and J. Banchereau, Cancer immunotherapy via dendritic cells, Nat. Rev. Cancer, vol.2012, issue.12, pp.265-277

J. Trinath, P. Hegde, M. Sharma, M. S. Maddur, M. Rabin et al., Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells, Blood, vol.122, issue.8, pp.1419-1427, 2013.
DOI : 10.1182/blood-2012-11-468264

M. S. Maddur, J. Trinath, M. Rabin, F. Bolgert, M. Guy et al., Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation, Cellular and Molecular Immunology, vol.65, issue.5, pp.650-652, 2015.
DOI : 10.4049/jimmunol.1101029

S. Holla, E. Stephen-victor, P. Prakhar, M. Sharma, C. Saha et al., Mycobacteria-responsive sonic hedgehog signaling mediates programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion, Scientific Reports, vol.2
DOI : 10.4049/jimmunol.0903174

URL : https://hal.archives-ouvertes.fr/hal-01304323

D. K. Banerjee, M. V. Dhodapkar, E. Matayeva, R. M. Steinman, and K. M. Dhodapkar, Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients, Blood, vol.108, issue.8, pp.2655-2661, 2006.
DOI : 10.1182/blood-2006-03-011353

P. Hegde, M. S. Maddur, A. Friboulet, J. Bayry, and S. V. Kaveri, Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2, PLoS ONE, vol.35, issue.10, p.26312, 2011.
DOI : 10.1371/journal.pone.0026312.t001

URL : https://hal.archives-ouvertes.fr/hal-00637405

C. Saha, P. Hegde, A. Friboulet, J. Bayry, and S. V. Kaveri, Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA, PLOS ONE, vol.70, issue.2, 2015.
DOI : 10.1371/journal.pone.0114965.g004

URL : https://hal.archives-ouvertes.fr/hal-01344611

DOI : 10.1081/IPH-100102567

H. Bantel, I. H. Engels, W. Voelter, K. Schulze-osthoff, and S. Wesselborg, Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis, Cancer Res, vol.59, pp.2083-2090, 1999.

A. Stettin, J. L. Schultze, E. Stechemesser, and P. A. Berg, Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived fromViscum album L. and neutralize lectin-induced cytotoxicity in vitro, Klinische Wochenschrift, vol.76, issue.227, pp.896-900, 1990.
DOI : 10.1007/BF01649034

V. Lavastre, M. Pelletier, R. Saller, K. Hostanska, and D. Girard, Mechanisms Involved in Spontaneous and Viscum album Agglutinin-I-Induced Human Neutrophil Apoptosis: Viscum album Agglutinin-I Accelerates the Loss of Antiapoptotic Mcl-1 Expression and the Degradation of Cytoskeletal Paxillin and Vimentin Proteins Via Caspases, The Journal of Immunology, vol.168, issue.3, pp.1419-1427, 2002.
DOI : 10.4049/jimmunol.168.3.1419

H. Walzel, M. Blach, P. Neels, U. Schulz, K. Wollenhaupt et al., The B-chain of mistletoe lectin I efficiently stimulates calcium signaling in human Jurkat T-cells, Immunology Letters, vol.78, issue.2, pp.57-66, 2001.
DOI : 10.1016/S0165-2478(01)00238-3

K. Kayser, H. J. Gabius, and S. Gabius, Biotinylated ligands for receptor localization: An alternative for immunohistochemistry, Zentralbl. Pathol, vol.137, pp.473-478, 1991.

C. Maletzki, M. Linnebacher, R. Savai, and U. Hobohm, Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy, Cancer Immunology, Immunotherapy, vol.17, issue.1, pp.1283-1292, 2013.
DOI : 10.1007/s00262-013-1455-1

H. J. Park, J. H. Hong, H. J. Kwon, Y. Kim, K. H. Lee et al., TLR4-mediated activation of mouse macrophages by Korean mistletoe lectin-C (KML-C), Biochemical and Biophysical Research Communications, vol.396, issue.3, pp.721-725, 2010.
DOI : 10.1016/j.bbrc.2010.04.169

R. A. Abagyan and S. Batalov, Do aligned sequences share the same fold?, Journal of Molecular Biology, vol.273, issue.1, pp.355-368, 1997.
DOI : 10.1006/jmbi.1997.1287

M. A. Horneber, G. Bueschel, R. Huber, K. Linde, and M. Rostock, Mistletoe therapy in oncology, Cochrane Database Syst. Rev, issue.2, p.3297, 2008.

D. Van-huyen, J. P. Bayry, J. Delignat, S. Gaston, A. T. Michel et al., Induction of apoptosis of endothelial cells by Viscum album: A role for anti-tumoral properties of mistletoe lectins, Mol. Med, vol.8, pp.600-606, 2002.

A. Bussing, K. Suzart, and K. Schweizer, Differences in the apoptosis-inducing properties of Viscum album L. extracts, S9?S14. [CrossRef], 1997.

E. Kovacs, Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract, Biomedicine & Pharmacotherapy, vol.54, issue.6, pp.305-310, 2000.
DOI : 10.1016/S0753-3322(00)80052-9

G. M. Stein, U. Edlund, U. Pfuller, and A. Bussing, Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro, Anticancer Res, vol.19, pp.3907-3914, 1999.

J. M. Braun, H. L. Ko, J. M. Schierholz, and J. Beuth, Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models, Anticancer Res, vol.22, pp.4187-4190, 2002.

D. Van-huyen, J. P. Delignat, S. Bayry, J. Kazatchkine, M. D. Bruneval et al., Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma, Cancer Letters, vol.243, issue.1, pp.32-37, 2006.
DOI : 10.1016/j.canlet.2005.11.016

M. Estko, S. Baumgartner, K. Urech, M. Kunz, U. Regueiro et al., Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro, BMC Complement. Altern. Med, pp.15-130, 2015.

C. I. Delebinski, M. Twardziok, S. Kleinsimon, F. Hoff, K. Mulsow et al., A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo, PLOS ONE, vol.125, issue.4, p.133892, 2015.
DOI : 10.1371/journal.pone.0133892.s001

S. Holla, M. Sharma, J. Vani, S. V. Kaveri, K. N. Balaji et al., GM-CSF along with IL-4 but not alone is indispensable for the differentiation of human dendritic cells from monocytes, Journal of Allergy and Clinical Immunology, vol.133, issue.5, pp.1500-1502, 2014.
DOI : 10.1016/j.jaci.2014.02.021